In Brief This Week: IntelligentMDx; Techne; Qiagen; Horizon Discovery; Penn Genome Frontiers Institute | GenomeWeb

NEW YORK (GenomeWeb News) – IntelligentMDx has received the CE Mark for its herpes simplex virus molecular test. The MDx HSV-1/2 runs on the Abbott m2000 platform and detects HSV viral DNA and differentiates HSV-1 and HSV-2 in male and female genital or oral lesions and cerebral spinal fluid.


Investment bank William Blair & Co. has initiated coverage of research reagents provider Techne with a Market Perform rating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.